USANA Health Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Schedule II - Valuation and Qualifying Accounts (Tables)

12 Months Ended

Jan. 01, 2022

Description	*Balance at beginning of period*		*Charged to costs and expenses*		*Deductions*		*Balance at end of period*

January 1, 2022
Allowance for sales returns	$	819	$	7,213	$	7,485	$	547
Allowance for doubtful accounts	$	372	$	148	$	16	$	504
Valuation allowance - deferred tax assets	$	81,401	$	18,557	$	-	$	99,958

January 2, 2021
Allowance for sales returns	$	772	$	115	$	68	$	819
Allowance for doubtful accounts	$	261	$	131	$	20	$	372
Valuation allowance - deferred tax assets	$	64,285	$	17,116	$	-	$	81,401

December 28, 2019
Allowance for sales returns	$	839	$	168	$	235	$	772
Allowance for doubtful accounts	$	139	$	146	$	24	$	261
Valuation allowance - deferred tax assets	$	44,199	$	20,086	$	-	$	64,285